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Abstract: 
 
Physical activity is predictive of better cognitive performance and lower risk of Alzheimer’s 
disease (AD). The apolipoprotein E gene (APOE) is a susceptibility gene for AD with 
the e4 allele being associated with a greater risk of AD. Cross-sectional and prospective research 
shows that physical activity is predictive of better cognitive performance for those at greater 
genetic risk for AD. However, the moderating role of APOE on the effects of a physical activity 
intervention on cognitive performance has not been examined. The purpose of this manuscript is 
to justify the need for such research and to describe the design, methods, and recruitment tactics 
used in the conductance of a study designed to provide insight as to the extent to which cognitive 
benefits resulting from an 8-month physical activity program are differentiated by APOE 
e4 status. The effectiveness of the recruitment strategies and the feasibility of recruiting APOE 
e4 carriers are discussed. 
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Article: 
 
The global prevalence of Alzheimer’s disease (AD) is predicted to reach 65.7 million by 
2030 (Alzheimer’s Disease International, 2009). Despite worldwide research efforts, a cure for 
AD has not been identified. Thus, it is critical to identify preventive strategies that reduce the 
risk of or delay the onset of AD (Emery, 2011). This has important public health implications, 
because a therapy that delays the development of AD by five years could reduce its risk by 50% 
(Brookmeyer, Gray, & Kawas, 1998). Physical activity holds promise as a behavioral therapy 
that benefits cognitive performance. Nonexperimental prospective studies have shown that 
physical activity is associated with better cognitive performance and a decreased risk of 
dementia (Abbott et al., 2004; Hamer & Chida, 2009; Kim et al., 2010; Lindsay et al., 2002). 
Quasi-experimental and experimental evidence indicates that participation in physical activity 
improves cognitive performance for samples of cognitively-normal adults (Angevaren, 
Aufdemkampe, Verhaar, Aleman, & Vanhees, 2008; Colcombe & Kramer, 2003; Heyn, Abreu, 
& Ottenbacher, 2004), patients with mild cognitive impairment (MCI) (Baker et al., 2010), and 
persons with memory complaints (Lautenschlager et al., 2008). Thus the extant literature 
supports the potential role of physical activity in the maintenance of cognitive performance.  
A question of particular interest relative to AD is if the effects of physical activity on 
cognitive performance differ as a function of a person’s genetic risk for AD. There is evidence 
that this is the case with respect to one particular gene that is predictive of AD. The 
apolipoprotein E gene (APOE) is a strong susceptibility gene for AD (Bu, 2009; Cedazo-
Minguez, 2007; Farrer et al., 1997; Gomez-Isla et al., 1996; Kim, Basak, & Holtzman, 2009; 
Myers et al., 1996). Compared with noncarriers, persons with one APOE epsilon 4 (e4) allele 
have three to four times greater risk (Bertram & Tanzi, 2008; Kapur, Sharad, Kapoor, & Bala, 
2006) and those with two APOE e4 alleles have five to 18 times greater risk of AD (Alzheimer’s 
Association Working Group, 1996).  
In addition, differences in preclinical biomarkers of AD (e.g., neurofibrillary tangles) as a 
function of APOE genotype appear in young to middle age (Kok et al., 2009; Morris et al., 
2010). Intriguingly, results from cross-sectional (Deeny et al., 2008; Etnier et al., 2007) and 
nonexperimental prospective studies (Niti, Yap, Kua, Tan, & Ng, 2008; Podewils et al., 2005; 
Rovio et al., 2005; Schuit, Feskens, Launer, & Kromhout, 2001) suggest that APOE moderates 
the relationship between physical activity or aerobic fitness and cognition, with larger benefits of 
physical activity typically reported for APOE e4 carriers (Deeny et al., 2008; Etnier et al., 2007; 
Niti et al., 2008; Rovio et al., 2005; Schuit et al., 2001). In addition, using a rodent model, 
Nichol et al. (2009) provided experimental evidence that participation in exercise causes 
cognitive benefits that are larger for apoE e4 carriers than noncarriers. Thus, APOE genotype 
may be a determinant of who benefits the most from a physical activity intervention. However, 
there is no published study with humans in which the effects of a physical activity intervention 
on cognition have been tested relative to APOE genotype. In addition to not fully understanding 
who benefits the most from physical activity, we also do not fully understand how physical 
activity benefits cognitive performance. Circulating brain-derived neurotrophic factor (BDNF) is 
one plausible mechanism of the effect of physical activity on cognitive performance. BDNF can 
be measured centrally in the brain (cBNDF), or peripherally in the blood (pBDNF). BDNF is a 
neurotrophic factor that is important for neuronal survival, growth, and maintenance and has 
been implicated in the consolidation of memory in animals (Johnston & Rose, 2001; Mu, Li, 
Yao, & Zhou, 1999; Patterson et al., 1996; Tang et al., 1998) and in humans (Egan, Weinberger, 
& Lu, 2003; Hariri et al., 2003). Although the results are not unequivocal, there is evidence that 
BDNF crosses the blood-brain barrier (Pan, Banks, Fasold, Bluth, & Kastin, 1998; Poduslo & 
Curran, 1996) and there is recent evidence that cBDNF correlates with pBDNF (Rasmussen et 
al., 2009; Seifert et al., 2010). With regard to AD, pBDNF decreases during the course of AD 
(Laske et al., 2006), and higher pBDNF is associated with slower decline in AD (Laske et al., 
2011). Importantly, in response to physical activity, increases in pBDNF are observed (Ferris, 
Williams, & Shen, 2007; Gold et al., 2003; Griffin et al., 2011; Rojas Vega et al., 2006) and 
there is evidence that brain tissue is the major contributor to the concentration of BDNF in the 
periphery (Rasmussen et al., 2009). Although the effects of chronic physical activity on BDNF 
are not consistent (Knaepen, Goekint, Heyman, & Meeusen, 2010; Zoladz & Pilc, 2010), there is 
some evidence that chronic physical activity increases pBDNF (Baker et al., 2010; Knaepen et 
al., 2010; Seifert et al., 2010; Zoladz et al., 2008), and a recent systematic review of randomized 
control trials conducted with older adults supports that chronic exercise increases resting levels 
of pBDNF (Coelho et al., 2013). Animal research also supports pBDNF as a mediator of the 
effects of physical activity on cognitive performance (Cotman & Berchtold, 2002; Cotman & 
Engesser-Cesar, 2002; Nichol et al., 2009; Vaynman, Ying, & Gomez-Pinilla, 2003, 2004), and 
Nichol et al. (2009) reported that changes in levels of BDNF receptors in response to physical 
activity were only evident for apoE e4 carriers. In sum, this evidence supports the possibility that 
pBDNF is a mechanism which could explain the effects of physical activity on cognitive 
performance (how), and which could potentially explain the moderating role of APOE on this 
effect (who).  
The purpose of this manuscript is to describe the design, methods, and recruitment 
strategies for the Physical Activity and Alzheimer’s Disease study (the PAAD study). The 
PAAD study was designed to identify the extent to which changes in cognitive performance that 
result from eight months of physical activity differ as a function of a person’s APOE genotype. 
Given that there is no published study in which the moderating role of APOE has been tested 
relative to a physical activity intervention, the provision of a detailed description of this study is 
meant to give guidance to future research in this area. Considerations made in the design of the 
study, detailed methods, recruitment efforts and effectiveness, and feasibility information 
regarding the recruitment of APOE e4 carriers for the study are presented herein. This 
information is intended to inform subsequent research exploring physical activity relative to 
genetic risk factors in general and relative to APOE specifically. 
 
Materials and Methods 
 
Overview 
 
Older adults with a family history of AD were recruited to participate in an eight-month physical 
activity program. To minimize experimenter and participant burden, research staff initially 
assessed an interested person’s eligibility for the study during a telephone interview. Eligible 
participants then visited the University of North Carolina at Greensboro campus for baseline 
testing, which consisted of additional screening instruments, provision of demographic 
information, performance of the cognitive test battery, and provision of a buccal sample for 
APOE genotyping. Participants who qualified for the study were invited in three cohorts to 
participate in the physical activity program. These individuals completed a pretest in the two 
weeks immediately before enrollment in the physical activity program, a midtest during the two 
weeks surrounding the completion of four months of exercise, and a posttest during the two 
weeks immediately following the eight months of exercise. At these sessions, participants 
provided blood samples to assess resting pBDNF, performed the cognitive test battery, and 
performed a submaximal aerobic fitness test. The physical activity program was individualized 
and progressive and consisted of walking and strength training exercises.  
We did not include a no-treatment control group in the current study. This decision was 
based upon the exploratory nature of this initial study and the financial and time limits of the 
funding mechanism. This decision is further motivated by the considerable past research (see 
Angevaren et al., 2008; Colcombe & Kramer, 2003) that has shown that physical activity 
interventions have a positive effect on the cognitive performance of older adults. In our current 
study, we intend to focus on whether APOE genotype moderates and pBDNF mediates changes 
in cognitive performance as a function of physical activity participation. We hypothesize that 
both APOE e4 carriers and noncarriers will show improvements in cognitive performance across 
the exercise intervention, but that improvements will be greater for APOE e4 carriers than for 
noncarriers. We also hypothesize that changes in resting pBDNF across time will partially 
mediate observed changes in cognitive performance over time. If findings support the 
hypotheses, future work will include a no-treatment control group so that conclusions regarding 
causality will be possible. 
 
Participants 
 
Cognitively normal, community-dwelling adults aged 49–65 years with a self-reported family 
history of AD were recruited for the study. Adults who were 49 at the time of screening but 
would be 50 for the majority of the exercise intervention and met all other inclusion criteria were 
allowed to participate. Adults older than 65 years were not recruited because this would likely 
result in an over-representation of APOE e4 noncarriers (Frikke-Schmidt, Nordestgaard, 
Agerholm-Larsen, Schnohr, & Tybjaerg-Hansen, 2000; McKay et al., 2011). Recruiting persons 
with a family history of AD was a strategy used to increase the numbers of volunteers who were 
APOE e4 carriers. APOE e4 carriers make up approximately 23% of the general U.S. population 
aged 60 and older (Raber, Huang, & Ashford, 2004). However, based upon our own (Etnier et 
al., 2007) and other research (Caselli, personal communication, December 9, 2008), recruiting 
adults with a family history of AD was expected to increase the percent of APOE e4 carriers to > 
30%. Cognitive normality was a requirement because we did not want to include persons who 
were already experiencing clinical cognitive decline. 
 
Recruitment 
 
Recruitment was conducted through a variety of methods, particularly targeting audiences in the 
desired age range and, when possible, persons who might be expected to have a family history of 
AD. Participants were asked how they had learned about the study to provide information 
regarding the most effective recruitment avenues. 
 
Genetic Information 
 
Although the withholding of genetic information collected as a part of a research study is an 
issue that is currently under debate (Lee & Lin, 2013), participants in this study were informed 
that based upon ethical considerations and in compliance with current recommendations 
(Alzheimer’s Association Working Group, 1996), they would not be given information about 
their genotype. This is because there is currently no treatment for AD and having information 
about a heightened genetic risk for AD might lead to mental distress. Genotype information was 
linked to an ID# and was not made available to participants or to intervention or research staff 
who interacted directly with participants. 
 
Inclusion Criteria 
 
Inclusion criteria were assessed during a telephone interview. Eligible participants had to self-
report having one first-degree family member (mother, father, sister, brother) or two second-
degree relatives (grandparent, aunt, uncle, niece, nephew) who had been diagnosed with AD. 
Participants also had to be between 49–65 years of age, able to communicate in English, and 
sedentary (30 min of moderate intensity physical activity fewer than five times a week for the 
last three months assessed by self-report) as defined by the Guidelines of the American College 
of Sports Medicine (ACSM, 2010). We did not include currently active adults because they are 
less likely to benefit from the intervention, and they are likely to experience ceiling effects on 
their cognitive performance that would inhibit our ability to test whether APOE e4 carriers 
differentially benefit from the intervention. 
 
Exclusion Criteria 
 
Participants were excluded if they met the criteria for clinical cognitive impairment, had 
contraindications to being physically active, self-reported any history of confounding illnesses or 
the use of medications that influence cognition, or had uncorrectable visual impairment or 
hearing loss that impacted their ability to be in the study.  
 
Clinical Cognitive Impairment. Clinical cognitive impairment (MCI, AD, or other forms of 
dementia) was assessed in two steps. First, during the telephone interview, the modified 
Telephone Interview for Cognitive Status (TICS-m) was administered. This is a 13-item 
telephone-administered screening instrument with scores ranging from 0–50. The TICS-m has 
acceptable sensitivity and specificity in the detection of dementia (Manly et al., 2011) and 
amnestic MCI (Cook, Marsiske, & McCoy, 2009). Participants who scored < 36 were excluded 
(Cook et al., 2009). Second, at baseline, participants completed the Folstein Mini-Mental Status 
Exam (MMSE), a 30-point screening tool for global cognitive functioning. Concurrent validity 
with the Wechsler Adult Intelligence Scale (r = .66–.78) and test-retest reliability (r = .83–.98) 
have been established (Folstein, Folstein, & McHugh, 1975). Participants had to score at least 27 
and at least 1 out of 3 on the recall subtest to be included in the study (Crum, Anthony, Bassett, 
& Folstein, 1993). This cutpoint is well above the conventional cut-points used to indicate 
possible cognitive impairment (score > 24 for individuals with > eighth-grade education or score 
> 21 for < eighth-grade education) and was chosen to reduce the likelihood of including persons 
with existing cognitive impairment (MCI, dementia) (Caselli et al., 2009).  
 
Contraindications to Physical Activity. Contraindications to physical activity were also assessed 
in two stages. This was first assessed during the telephone interview using the American Heart 
Association/ACSM Health/Fitness Facility Preparticipation Screening Questionnaire (PrepartQ) 
as per the Guidelines of the ACSM (2010). The second assessment was performed using a 
medical health history (MHH), which was completed during the baseline visit. Participants were 
judged as unable to perform physical activity if they reported functional limitations, use of 
medications that suppress heart rate (i.e., beta-blockers, calcium-channel blockers), active and/or 
symptomatic heart disease, or pulmonary or metabolic diseases. In addition, all participants were 
required to submit a permission to participate form that was signed by their physician.  
 
Confounding Conditions. The MHH was also used to identify confounding illnesses or 
medications that affect cognition. Confounding illnesses that resulted in exclusion included 
neurologic (e.g., traumatic brain injury, prior stroke, myelopathy, myopathy, peripheral 
neuropathy), psychiatric (e.g., active major depression, any history of schizophrenia or bipolar 
disorder), active severe or functionally disabling neurologic or medical diseases (e.g., 
Parkinson’s disease, active treatment for cancer), or any other conditions that might limit 
exercise or pose a danger to the patient. 
 
Uncorrectable Visual Impairment or Hearing Loss. This was assessed subjectively during the 
baseline testing when participants interacted with the research staff.  
 
Peripheral Brain-Derived Neurotrophic Factor. Standard protocols were followed with regard to 
BDNF collection, storage, assays, and analyses. Blood samples were collected from an arm vein 
at rest (Knaepen et al., 2010). Plasma and serum were separated by centrifugation. Samples were 
stored at –80 °F and analyses for pBDNF will be conducted as cohorts complete the posttest 
using the Quantikine BDNF enzyme-linked immunosorbent assay (ELISA) (R & D Systems, 
Minneapolis, MN). 
 
Cognitive Test Battery 
 
We selected tests to assess cognitive performance across a range of cognitive domains and to 
specifically include tests assessing cognitive abilities sensitive to the early stages of dementia 
(Lezak, Howieson, & Loring, 2004) and to physical activity interventions (Colcombe & Kramer, 
2003). All measures have been used extensively, have well-established psychometrics, are not 
reliant on a particular reading level, and have age-appropriate normative data adjusted for 
education level (when relevant). Information processing speed was assessed with the Wechsler 
Adult Intelligence Scale III (WAIS-III) Digit Symbol Task (raw score). Memory (immediate 
recall, delayed recall, and retroactive and proactive interference) was measured using the 
Auditory Verbal Learning Test. Delayed visuospatial memory and constructional praxis were 
measured using the Rey-Osterrieth Complex Figure Test. Attention was assessed using the Paced 
Auditory Serial Addition Test (3- and 2-s tests) and forward and backward Digit Span measures 
from the WAIS-III (raw scores). Executive function was measured using the Trail-Making Tests 
A and B and the Stroop Test. Visuospatial perception was assessed with the Judgment of Line 
Orientation. Perceptions of the ability to perform real-world cognitive activities was measured 
with the Pincus Cognitive Symptoms Inventory. 
 
Submaximal Aerobic Fitness 
 
Aerobic fitness was estimated using a submaximal exercise test. Participants walked as quickly 
and as far as possible around a marked track during a 6-min period. This submaximal measure of 
aerobic fitness is appropriate for use with older adults and provides an accurate estimate of 
VO2peak (Steele, 1996). 
 
Covariates 
 
Identifying individual difference variables that discriminate levels of responsiveness to the 
intervention may provide important insights for subsequent research. Although sample size 
limitations will preclude our ability to statistically examine the effects of covariates on the 
relationship between physical activity and cognitive performance, data on variables that have 
been identified as important in past research (Abbott et al., 2004; Lytle, Vander Bilt, Pandav, 
Dodge, & Ganguli, 2004; Weuve et al., 2004; Yaffe, Barnes, Nevitt, Lui, & Covinsky, 2001) 
were collected at baseline and will be explored to potentially provide guidance for future 
research. These include: age, education, smoking, medications and supplements, body mass 
index (BMI), menopausal status, hormone therapy use, and cardiovascular risk factors. In 
addition, participants completed the Community Healthy Activities Model Program for Seniors 
(CHAMPS) Questionnaire (Stewart et al., 2001; Stewart et al., 1997) to assess physical activity 
level at baseline so that initial activity level could be considered as a potential covariate. The 
CHAMPS includes leisure, work, housework, and social activities, and has established three-
month stability and construct validity (Harada, Chiu, King, & Stewart, 2001). 
 
Procedures 
 
Interested individuals were contacted by project staff by telephone. After hearing a description of 
the study, individuals who remained interested answered questions to ascertain initial eligibility 
for the study. Responses were entered into a web form created specifically for the PAAD study. 
This form included the script for the experimenters, recorded the data, and was programmed to 
evaluate participants’ responses using logic statements to determine whether a participant 
qualified for the study and to direct the experimenter to the appropriate final information screen 
(i.e., eligible or not eligible). Eligible participants were scheduled for baseline testing. 
Participants who were not eligible were told why they were excluded and, as appropriate 
depending upon their reason for exclusion, were encouraged to consult with their personal 
physician and were given contact information for a geriatric nurse practitioner on the research 
team.  
This study was approved by the university’s institutional review board, and participants 
read and signed an approved informed consent document at the baseline testing session. 
Participants had their height and weight measured, provided demographic information and 
information regarding potential covariates, completed the Geriatric Depression Scale (GDS), the 
PrepartQ, the MHH, and performed the MMSE. They then performed the cognitive test battery 
and provided two buccal samples (i.e., cheek swabs) that were used to assess APOE genotype.  
At the pretest, midtest, and posttest, participants first had their blood drawn for the BDNF 
sample. To control for diurnal and dietary variations in pBDNF, participants were asked to fast 
for 8 hr and testing began before 9:00 a.m. Participants provided a blood sample to assess resting 
pBDNF. They were then offered a light breakfast that was made available throughout the testing 
session. Participants then performed the cognitive test battery which was followed by 
performance of the submaximal exercise test. All experimenters who interacted with participants 
were unaware of participants’ APOE genotypes. 
 
Physical Activity Intervention 
 
The design of the physical activity intervention is based upon metaanalytic evidence (Colcombe 
& Kramer, 2003) indicating that the largest effects of physical activity on cognition in older 
adults are observed for programs that include both aerobic and strength training (g = 0.59) and 
last longer than six months (g = 0.67). Thus, the physical activity intervention consisted of 
aerobic exercise (walking) and strength training offered in 35–60-min sessions.  
Exercise sessions were offered from 8–9 a.m. and 12–1 p.m. on Monday, Wednesday, 
and Friday, and from 6–7 p.m. on Monday, Tuesday, and Thursday. Subjects were asked to 
attend three times a week for eight months. Each subject walked at a target heart rate of 60% of 
heart rate reserve calculated using the Karvonen method, and a 10-s heart rate was recorded after 
10 min of walking at every session. Periodically, individual data were examined so that the target 
heart rate could be adjusted, if necessary, for that individual. For strength training, elastic 
TheraBands (Akron, OH) were used. Subjects began with bands which provided the least 
resistance, completing one set of 10 repetitions for each of 10–12 exercises. As they 
demonstrated that they could complete 15 repetitions for any given exercise in proper form, they 
progressed to the next higher resistance band for that exercise, dropping back to eight repetitions 
and progressing to 15 repetitions over time at the new resistance. Detailed records were kept at 
every exercise session reflecting the distance and time walked (recorded by the experimenter) 
and the strength training exercises performed (exercise, band color, sets, repetitions recorded by 
the participant). Given that we needed to instruct the participants on the proper form for the 
strength training exercises and on how to record their data, sessions during the first two weeks of 
the program consisted of approximately 20 min of strength training and 15 min of walking. The 
duration of the strength training portion increased quickly as participants became familiar with 
the exercises and the duration of walking increased as participants increased their walking 
capacity. By the third week, sessions included 50–60 min of exercise made up of 20 min of 
walking and approximately 30–40 min of strength training. This physical activity program was 
chosen because it is inexpensive, safe, and exportable into community older adult programs and 
into the homes of older adults. 
 
Statistical Analyses 
 
Descriptive data are reported relative to recruitment efforts and outcomes. Feasibility of 
recruiting a sample for participation in an eight-month physical activity program conducted on 
the university campus is considered by examining descriptive data to understand reasons for not 
being included in the study and reasons for dropping out of the study. Feasibility of recruiting 
sufficient APOE e4 carriers for statistical comparisons was tested by using a χ2 analysis to 
compare the proportion of carriers versus noncarriers in the sample to that of the general 
population. Our ability to recruit a sample of participants representative of the community was 
assessed in several ways. First, representativeness of the final sample was assessed by comparing 
drop-outs to those who enrolled in the exercise program. Second, representativeness was 
considered by comparing descriptive data with regard to age group, sex, ethnicity, and race for 
participants who expressed interest in the study and for participants enrolled in the exercise 
program to those of the population of older adults in the community. In these comparisons, 
analyses of variance (ANOVA) were used for MMSE, BMI, education, and GDS scores and χ2 
analyses were used for APOE genotype, age group, sex, marital status, income, employment, and 
smoking status. Due to small cell sizes, data on ethnicity and race were compared using Fisher’s 
exact test, for which only a p-value is reported. 
 
Results 
 
Recruitment 
 
Recruitment of participants began in October 2012 and continued for 11 months. These efforts 
were categorized (denoted in brackets) to help identify the most effective recruitment avenues. 
First described are the recruitment avenues that did not require a direct cost (assessment of 
experimenter time in the creation of advertising or in the conductance of interviews was not 
considered as this was built into the grant in terms of percent effort).  
The study description was published in a newsletter sent via e-mail to persons involved in 
the Community A+ Program for Disabled Adults, Adult Health Day Center, In-Home-Aid, and 
Home Care Agency on two occasions, reaching approximately 300–400 caregivers in 
approximately 30–40 agencies on one occasion, and 94 Adult Day Care members on one 
occasion [e-mail]. Employers with business offices in the Greensboro area that employed > 
1,000 employees in the Triad (Greensboro, Highpoint, Winston-Salem) area (n = 16) were 
identified from the local Business Journal’s 2012 Book of Lists and were contacted to request 
that information regarding the PAAD study be distributed to employees [e-mail]. The researchers 
gave presentations on physical activity and health and handed out flyers at a Rotary Club 
meeting and at an Alzheimer’s support group meeting [talks]. A story describing the study 
appeared in three free circulations: Women Go and Do magazine, the Triad Retirement Guide, 
and the University’s campus newspaper [free ad]. A public service announcement appeared on 
the local PBS television station and one of the researchers was interviewed on a local television 
station during the morning news [TV]. NPR aired an interview with the primary investigator 
twice during the morning commute and once during the evening commute (on a single day) [free 
ad].  
Other recruitment avenues had a direct cost associated with them. Flyers (cost including 
printing and postage = $263) were delivered through the mail to approximately 200 caregivers on 
two occasions; were handed out to approximately 400 participants in the Alzheimer’s 
Association walk (cost for table = $125); and were posted in four Department of Social Services 
facilities, 14 senior living facilities, 3 physician offices, 3 home health care providers, and 24 
churches or synagogues [flyers]. Advertisements for the study were published in the local 
newspaper on six occasions at a total cost of $1,784 [paper] and in the local Business Journal on 
two occasions at a total cost of $746 [journal]. Advertisements were aired on the two radio 
stations that have the highest average rating for adult listeners aged 50–64 years. These 
advertisements were aired on the radio stations 39 times over a weekly period at a cost of $1,089 
(WPAW) and 26 times in one week at a cost of $976 (WQMG) [radio]. Advertisements were 
also aired on the local NPR station 10 times during the morning commute and 10 times during 
the evening commute over a two-week period (cost = $1,000) [radio]. A domain was purchased 
(cost = $18) and was made accessible through the department’s home page, the university 
Facebook page, and a Facebook page created for the study [web]. This web page included study 
information and a web form that participants could submit to express their interest in the study 
and contact information. The web page and web form were created by a staff person at no cost to 
the study. A click-through was posted for two months on a website hosted by the Senior Living 
Guide ($200), which allowed participants to click to the study web page [SLG].  
Data regarding recruitment provided the following information relative to the sources 
through which participants learned of the study (see Table 1). As is evident from the data, the 
most effective recruiting method was advertising in the local newspaper. This method of 
recruitment resulted in the largest number of contacts for the study and also an estimated cost per 
person that equaled the mean cost for all participants for the study. Notably, the number of 
participants who reported hearing about the study in the newspaper was larger following the first 
(n = 29) as compared with the second running (n = 15) of the advertisement, which may suggest 
diminishing returns. The advertisements on the radio were also effective in that a large number 
of contacts were obtained, but at a much higher estimated cost per person as compared with the 
newspaper ads. Of additional interest, the distribution of flyers and the use of a study web page 
were effective methods of recruitment and the cost per participant was relatively low. The free 
advertising on the television through the public service advertisement and the interview was also 
effective and, of course, this is of great value since there were no costs associated other than the 
time of the principal investigator who had percent effort built into the grant. Lastly, many 
participants reported that they heard of the study by word of mouth. Although we cannot identify 
the particular source that resulted in their knowledge of the study, this does likely suggest the 
value in using a wide spectrum of recruitment avenues to create a conversation about the study in 
the community. 
 
 
 
Feasibility 
 
One of the important considerations in conducting this study in Guilford County and the Triad 
(Greensboro, Highpoint, WinstonSalem) area was to determine whether it is feasible to recruit 
sufficient numbers of individuals who meet the eligibility requirements, who are able to attend 
the physical activity program on a university campus three days per week for eight months, and 
who (as a sample) provide a good representation of APOE e4 carriers and noncarriers.  
The consort flow diagram (see Figure 1) provides information regarding sample size 
relative to inclusion/exclusion criteria and interest in participating. The largest percentage of 
participants was lost as a result of not meeting criteria identified during the telephone interview 
(41%). Of this group, most did not meet the minimum score for inclusion on the TICS-m (21%), 
had no family history of AD (16%), or were already too physically active (14%). Of the 80 who 
were eligible for the study after the telephone interview, 66 completed the baseline testing on 
campus while 14 decided that they were no longer interested in participating in the study. Of the 
66 who completed baseline testing, 54 began the exercise program, nine chose not to participate, 
and three had to be excluded for health reasons identified during baseline testing (i.e., asthma, 
major depression, diabetes).  
With regard to genotype, data relative to each specific genotype are presented in Table 2. 
The recruitment technique resulted in a sample of 54 exercisers consisting of 18 carriers (e3/e4, 
e4/e4) and 36 noncarriers (e2/e3, e2/e4, e3/e3). Persons with the e2/e4 genotype were considered 
noncarriers because of evidence that the e2 allele (which is protective against AD) mitigates the 
risk typically conferred by the e4 allele (Raber et al., 2004). In comparison with the expected 
distribution of carriers versus noncarriers (23% vs. 77%) in the U.S. population age 60 and older 
(Raber et al., 2004), this sample consisted of significantly more carriers (34%) than expected, χ2 
(1, n = 54) = 6.83, p < .05. 
 
 
 
 
 Analyses were conducted to identify whether there were differences between the 12 
participants who were baseline tested, but did not participate in the exercise program and the 54 
participants who enrolled in the exercise program. Results of ANOVAs indicated that there were 
no significant differences between the groups in MMSE, F(1,65) = 0.47, p > .05; BMI, F(1,65) = 
2.95, p > .05; education, F(1,65) = 0.001, p > .05; or GDS, F(1,65) = 3.13, p > .05. Chi-square 
analyses showed that there were no significant differences (p > .05) in the distribution of APOE 
genotype, χ2(4, n = 66) = 5.20; sex, χ2(1, n = 66) = 2.99; marital status, χ2 (2, n = 66) = 2.24; 
income, χ2 (5, n = 66) = 5.82; or employment, χ2 (4, n = 66) = 1.37, between the groups. There 
was a significant difference in smoking status, χ2 (2, n = 66) = 7.92, p < .05, between the groups. 
However, upon removal of the three participants who were excluded from the study due to health 
reasons, this difference was no longer statistically significant, χ2 (2, n = 63) = 3.30, p > .05.  
Comparisons were also made between the sample who contacted us with interest in 
participating and data from the 2005–2009 American Community Survey for 49–65-year-olds in 
Guilford County to ascertain the extent to which the recruiting efforts were reaching a 
representative sample of county residents. Results indicated that there were no significant 
differences between contacts and Guilford County residents for age group, χ2 (2, n = 116) = 
3.39, p = .18; ethnicity (p = 1.00); or race (p = .60). However, there was a significant difference 
in sex, χ2(1, n = 119) = 30.47, p < .001. The contacts included more women and fewer men than 
expected.  
Lastly, data were compared between the participants who started the exercise program 
and relevant population data to identify the extent to which the exercisers are representative of 
the community of adults ages 49–65. In particular, data on sex, race, ethnicity, and age group 
(49–54, 55–59, 60–65) were compared with data from the 2005–2009 American Community 
Survey, which provides data for adults between the ages of 49–65 in Guilford County. Similar to 
the comparison between the contacts and the county data, these results indicated that the 
exercisers were representative with regard to age group, χ2(2, n = 54) = 4.10, p =.10, and 
ethnicity (p = .50), but were not representative with regard to sex (differences in the same 
direction as previously described). This comparison showed that there was also a significant 
difference in race (p = .01) with the exercises, including more Whites and fewer Blacks than 
expected.  
Demographics for the contacts and for the final sample of 54 participants are displayed in 
Table 3. 
 
TABLE 3 IS OMITTED FROM THIS FORMATTED DOCUMENT 
 
Discussion 
 
Data collected during the recruitment and initial testing of participants provide guidance for 
future research of a similar nature. In particular, a total of $6,201 was spent on recruitment over 
11 months and this resulted in contact by 151 interested people; ultimately, 54 individuals 
qualified and remained willing to participate in the study. Considering the 54 enrolled in the 
exercise program, the cost per person for recruitment was ~$115. It should be remembered, 
however, that there were many additional efforts that did not cost money and that may have 
contributed to the number of participants who reported hearing about the study by word of 
mouth. Given that 14% of those who expressed interest in the study heard about the study by 
word of mouth, there is support for the need to use all recruitment avenues available to ensure 
that as many eligible people as possible become aware of the study. The data from recruitment 
efforts can also provide guidance as to how to increase the number of people enrolled in the 
study. For example, the targeted enrollment number for the study was 60. Thus, the data indicate 
that spending approximately ~$700 more on recruitment may have yielded the targeted 
enrollment.  
Evidence indicates that it is feasible to recruit eligible persons between the ages of 49–65 
years to participate in an on-campus exercise program for three days per week for eight months. 
Importantly, the recruited sample consisted of 34% APOE e4 carriers. Given that the primary 
research question is to explore differences in the cognitive benefits of the eight-month physical 
activity program as a function of e4 carrier status, obtaining an acceptable percentage of carriers 
was critical. The goal in using this recruitment technique was to recruit a sample of which 30% 
were carriers, hence the strategy of recruiting persons with a family history of AD was effective.  
The exercisers who participated in the study were representative of the community in 
Guilford County with regard to age group and ethnicity, but not in terms of sex and race. This 
may limit the generalizability of the findings of this study. With regard to sex, significantly more 
women were recruited and participated relative to the general population. It is typical of exercise 
interventions with sedentary older adults to have a larger percentage of female participants as 
compared with male participants. This is evidenced from observations in 37 randomized 
controlled trials with older adults (M = 68.4 years) indicating that approximately 65% of 
participants have been female. With regard to race, a significantly smaller percentage of our 
exercisers were African Americans than would be expected with random sampling of the 
community. This limitation may have been a result of our inability to advertise effectively to this 
population. However, given that we targeted our advertisements to persons with a family history 
of AD, this disparity may also be explained by evidence that African Americans have a lower 
perceived risk of AD than non-Latino Whites (Chung, Mehta, Shumway, Alvidrez, & Perez-
Stable, 2009).  
The use of the telephone interview was of value in terms of minimizing the burden on 
potential participants and on research staff. In particular, the telephone interview allowed for the 
identification of 59 volunteers who were ineligible before asking them to visit the university for 
baseline testing. This was important from the perspective of the grant because it saved 
approximately 120 hr of time for testing (three weeks of full-time effort) and approximately $700 
($2 for parking and $10 for a gift card for completion of testing). The efficacy of the telephone 
interview is also evidenced by the fact that only three of the 80 (~4%) found eligible after the 
telephone interview had to be excluded from the study for health reasons. The relatively large 
number of participants who chose not to participate after the baseline interview (n = 14) may 
indicate that more information regarding the requirements of the study need to be shared during 
the telephone interview so that participants can more accurately judge their interest in 
participating in the study.  
In sum, initial data support our ability to recruit participants with a family history of AD 
who meet inclusion criteria and do not meet exclusion criteria and are willing to participate in an 
eightmonth physical activity program. The percentage of APOE e4 carriers approximated our 
expectations (obtained 34%, expected 23%), hence giving us sufficient carriers to explore the 
moderating effect of this variable on the cognitive benefits observed in response to the physical 
activity program. Generalizability of the results will be limited by our inability to enroll 
representative numbers of men and African Americans in the study. Future research conducted in 
this area will need to consider the incorporation of additional or different strategies to improve in 
this regard. 
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